STERIS (STE) Financials

$245.03 -1.17 (-0.48%)

Closing price 05/28/2025 03:59 PM Eastern

Extended Trading

$245.07 +0.04 (+0.02%)

As of 05/28/2025 04:24 PM Eastern

Annual Income Statements for STERIS

This table shows STERIS's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017
Period end date	3/31/2024	3/31/2023	3/31/2022	3/31/2021	3/31/2020	3/31/2019	3/31/2018	3/31/2017
Net Income / (Loss) Attributable to Common Shareholders	378	107	244	397	408	304	291	110
Consolidated Net Income / (Loss)	380	106	243	397	408	305	292	111
Net Income / (Loss) Continuing Operations	553	556	284	397	408	305	292	111
Total Pre-Tax Income	703	680	367	518	499	369	355	185
Total Operating Income	836	791	478	548	537	411	400	226
Total Gross Profit	2,218	1,981	1,883	1,343	1,320	1,175	1,093	1,026
Total Revenue	5,139	4,536	4,223	3,108	3,031	2,782	2,620	2,613
Operating Revenue	5,139	4,536	4,223	3,108	3,031	2,782	2,620	2,613
Total Cost of Revenue	2,921	2,556	2,340	1,764	1,711	1,607	1,527	1,587
Operating Cost of Revenue	2,921	2,556	2,340	1,764	1,711	1,607	1,527	1,587
Total Operating Expenses	1,382	1,190	1,405	795	783	764	693	800
Selling, General & Admin Expense	1,252	1,091	1,318	731	717	670	632	682
Research & Development Expense	104	98	87	66	66	63	61	59
Restructuring Charge	26	0.49	0.05	-2.91	0.67	31	0.10	0.22
Total Other Income / (Expense), net	-133	-111	-111	-31	-38	-42	-45	-42
Interest Expense	144	108	89	37	40	45	51	45
Other Income / (Expense), net	11	-2.88	-22	6.35	1.99	3.02	5.73	2.96
Income Tax Expense	150	124	82	121	91	64	63	74
Net Income / (Loss) Discontinued Operations	-173	-450	-42	-	-	-	-	-
Net Income / (Loss) Attributable to Noncontrolling Interest	1.84	-1.22	-1.02	-0.53	0.20	1.03	0.71	0.67
Basic Earnings per Share	$3.83	$1.07	$2.50	$4.66	$4.81	$3.59	$3.42	$1.29
Weighted Average Basic Shares Outstanding	197.80M	197.30M	200.16M	170.74M	84.92M	84.54M	-	-
Diluted Earnings per Share	$3.81	$1.07	$2.48	$4.63	$4.76	$3.55	$3.39	$1.28
Weighted Average Diluted Shares Outstanding	197.80M	197.30M	200.16M	170.74M	84.92M	84.54M	-	-
Weighted Average Basic & Diluted Shares Outstanding	197.80M	197.30M	200.16M	170.74M	84.92M	84.54M	-	-
Cash Dividends to Common per Share	$2.03	$1.84	$1.69	$1.57	$1.45	$1.33	$1.21	$1.09

This table shows STERIS's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022	6/30/2022
Net Income / (Loss) Attributable to Common Shareholders	174	150	145	-1.38	141	115	124	187	124	-315	111
Consolidated Net Income / (Loss)	173	151	146	-1.00	141	116	124	187	123	-315	111
Net Income / (Loss) Continuing Operations	173	151	140	172	149	121	131	637	123	-315	111
Total Pre-Tax Income	229	195	175	215	190	156	167	718	160	-333	135
Total Operating Income	245	220	186	245	226	192	198	748	191	-306	158
Total Gross Profit	610	579	572	449	560	546	529	409	521	532	518
Total Revenue	1,371	1,329	1,280	1,116	1,298	1,238	1,183	963	1,216	1,201	1,156
Operating Revenue	1,371	1,329	1,280	1,116	1,298	1,238	1,183	963	1,216	1,201	1,156
Total Cost of Revenue	760	750	707	668	738	692	654	554	694	668	639
Operating Cost of Revenue	760	750	707	668	738	692	654	554	694	668	639
Total Operating Expenses	365	359	387	203	334	355	331	-339	331	839	359
Selling, General & Admin Expense	335	329	336	152	308	328	307	128	305	323	335
Research & Development Expense	27	27	26	25	25	26	25	23	26	25	25
Restructuring Charge	2.23	2.80	26	26	0.01	-0.02	0.02	0.36	0.04	0.06	0.03
Total Other Income / (Expense), net	-17	-25	-10	-30	-37	-36	-31	-30	-30	-27	-23
Interest Expense	19	20	30	36	39	37	32	31	29	26	23
Other Income / (Expense), net	2.55	-5.11	20	6.33	2.08	1.24	1.38	0.32	-1.91	-0.52	-0.77
Income Tax Expense	55	44	35	43	41	35	36	81	37	-18	24
Net Income / (Loss) Discontinued Operations	-0.08	-0.21	5.59	-	-7.66	-4.45	-6.79	-	-	-	-
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.25	1.14	0.14	0.38	0.20	1.03	0.24	-0.26	-0.50	0.05	-0.51
Basic Earnings per Share	$1.76	$1.52	$1.47	($0.01)	$1.42	$1.17	$1.25	$1.87	$1.24	($3.15)	$1.11
Weighted Average Basic Shares Outstanding	98.25M	98.71M	197.23M	197.80M	197.63M	197.60M	197.56M	197.30M	198.57M	199.65M	200.03M
Diluted Earnings per Share	$1.75	$1.51	$1.46	($0.02)	$1.42	$1.16	$1.25	$1.88	$1.24	($3.15)	$1.10
Weighted Average Diluted Shares Outstanding	98.25M	98.71M	197.23M	197.80M	197.63M	197.60M	197.56M	197.30M	198.57M	199.65M	200.03M
Weighted Average Basic & Diluted Shares Outstanding	98.25M	98.71M	197.23M	197.80M	197.63M	197.60M	197.56M	197.30M	198.57M	199.65M	200.03M
Cash Dividends to Common per Share	$0.57	$0.57	$0.52	$0.52	$0.52	$0.52	$0.47	$0.47	$0.47	$0.47	$0.43

This table details how cash moves in and out of STERIS's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017
Period end date	3/31/2024	3/31/2023	3/31/2022	3/31/2021	3/31/2020	3/31/2019	3/31/2018	3/31/2017
Net Change in Cash & Equivalents	-1.34	-140	128	-99	99	19	-81	34
Net Cash From Operating Activities	973	757	685	690	591	540	458	424
Net Cash From Continuing Operating Activities	973	750	685	690	591	540	458	424
Net Income / (Loss) Continuing Operations	380	106	243	397	408	305	292	111
Consolidated Net Income / (Loss)	380	106	243	397	408	305	292	111
Depreciation Expense	565	553	553	219	197	226	178	188
Amortization Expense	4.82	-	67	0.00	0.00	-	-	-
Non-Cash Adjustments To Reconcile Net Income	301	527	78	50	26	5.12	72	151
Changes in Operating Assets and Liabilities, net	-277	-436	-256	23	-40	3.72	-84	-26
Net Cash From Investing Activities	-887	-383	-667	-1,154	-320	-213	-204	-104
Net Cash From Continuing Investing Activities	-887	-383	-667	-1,154	-320	-213	-204	-104
Purchase of Property, Plant & Equipment	-360	-362	-288	-239	-215	-190	-165	-173
Acquisitions	-546	-43	-550	-909	-110	-13	-46	-66
Purchase of Investments	-1.50	0.00	0.00	-4.40	0.00	-4.96	0.00	-6.36
Sale of Property, Plant & Equipment	7.38	15	1.74	0.57	4.16	5.57	2.09	4.85
Divestitures	9.46	6.62	170	0.52	0.44	2.48	8.89	136
Sale and/or Maturity of Investments	3.88	0.00	-	-	-	-	-	-
Net Cash From Financing Activities	-85	-499	116	346	-163	-295	-356	-267
Net Cash From Continuing Financing Activities	-85	-499	116	346	-163	-295	-356	-267
Repayment of Debt	132	1.83	-924	-78	-28	-113	-213	-370
Repurchase of Preferred Equity	0.00	-91	-721	-	-	-	-	-
Repurchase of Common Equity	-12	-309	-56	-15	-51	-81	-65	-98
Payment of Dividends	-208	-186	-197	-140	-125	-114	-106	-103
Issuance of Debt	0.00	242	2,010	577	35	13	29	-
Issuance of Common Equity	2.99	0.00	3.67	2.26	6.05	0.00	0.00	9.98
Effect of Exchange Rate Changes	-2.06	-	-6.29	20	-8.73	-12	21	-19

This table details how cash moves in and out of STERIS's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022	6/30/2022
Net Change in Cash & Equivalents	-17	-26	-8.69	11	-18	5.14	0.26	-51	1.11	-58	-32
Net Cash From Operating Activities	333	251	304	255	291	146	281	216	206	104	232
Net Cash From Continuing Operating Activities	333	255	304	255	291	146	281	211	203	104	232
Net Income / (Loss) Continuing Operations	173	151	146	-1.00	141	116	124	187	123	-315	111
Consolidated Net Income / (Loss)	173	151	146	-1.00	141	116	124	187	123	-315	111
Depreciation Expense	126	115	113	134	141	152	138	142	138	134	139
Non-Cash Adjustments To Reconcile Net Income	7.90	35	0.20	249	20	18	14	-2.64	4.80	502	22
Changes in Operating Assets and Liabilities, net	26	-47	45	-128	-15	-140	5.75	-116	-61	-220	-40
Net Cash From Investing Activities	-124	-105	688	-96	-119	-606	-67	-78	-98	-98	-109
Net Cash From Continuing Investing Activities	-124	-105	688	-96	-119	-606	-67	-78	-98	-98	-109
Purchase of Property, Plant & Equipment	-89	-102	-108	-91	-119	-83	-67	-71	-92	-83	-116
Acquisitions	-36	-3.81	-14	-6.50	-	-540	0.00	-8.55	-19	-15	0.00
Sale of Property, Plant & Equipment	0.00	-	0.00	0.01	0.02	7.36	0.01	2.42	11	0.04	1.29
Divestitures	1.52	0.35	810	-	-	9.46	0.00	-	1.40	-	5.23
Net Cash From Financing Activities	-214	-181	-999	-144	-198	470	-214	-192	-120	-45	-141
Net Cash From Continuing Financing Activities	-214	-181	-999	-144	-198	470	-214	-192	-120	-45	-141
Repayment of Debt	282	-92	-891	173	248	-14	-14	142	-15	-51	-75
Repurchase of Common Equity	-100	-46	-64	-0.33	-2.23	-0.49	-8.72	-155	-84	-45	-25
Payment of Dividends	-58	-56	-52	-51	-59	-51	-47	-48	-48	-47	-43
Issuance of Debt	-338	14	5.59	-266	-387	536	-145	25	117	98	1.22
Effect of Exchange Rate Changes	-12	9.46	-1.33	-	7.50	-4.93	-0.64	-	-	-	-13

This table presents STERIS's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018
Period end date	3/31/2024	3/31/2023	3/31/2022	3/31/2021	3/31/2020	3/31/2019	3/31/2018
Total Assets	11,064	10,822	11,424	6,574	5,441	5,073	5,200
Total Current Assets	2,869	2,011	1,879	1,212	1,224	1,054	990
Cash & Equivalents	207	208	348	221	320	221	202
Accounts Receivable	1,008	865	799	609	586	555	528
Inventories, net	675	604	575	315	264	208	206
Prepaid Expenses	174	176	157	67	54	60	54
Other Current Nonoperating Assets	805	158	-	-	-	-	-
Plant, Property, & Equipment, net	1,765	1,633	1,553	1,235	1,112	1,032	1,011
Total Noncurrent Assets	6,429	7,178	7,992	4,127	3,105	2,988	3,200
Goodwill	4,071	3,879	4,404	3,026	2,356	2,323	2,434
Intangible Assets	2,119	2,077	3,329	898	565	605	727
Other Noncurrent Operating Assets	239	244	259	203	183	60	39
Total Liabilities & Shareholders' Equity	11,064	10,822	11,424	6,574	5,441	5,073	5,200
Total Liabilities	4,748	4,735	4,879	2,683	2,023	1,887	1,983
Total Current Liabilities	931	862	922	578	504	465	398
Short-Term Debt	86	60	143	0.00	20	0.00	-
Accounts Payable	252	264	226	157	149	153	136
Accrued Expenses	320	298	307	221	192	188	168
Current Deferred & Payable Income Tax Liabilities	14	40	27	28	14	15	0.38
Current Employee Benefit Liabilities	165	118	184	150	128	109	94
Other Current Liabilities	31	30	36	23	-	-	-
Other Current Nonoperating Liabilities	64	51	-	-	-	-	-
Total Noncurrent Liabilities	3,817	3,873	3,957	2,105	1,519	1,422	1,585
Long-Term Debt	3,120	3,019	2,945	1,651	1,151	1,183	1,316
Capital Lease Obligations	146	140	155	130	114	0.00	-
Noncurrent Deferred & Payable Income Tax Liabilities	480	618	781	237	164	151	160
Other Noncurrent Operating Liabilities	72	76	76	88	90	88	109
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	6,315	6,087	6,545	3,891	3,418	3,186	3,217
Total Preferred & Common Equity	6,302	6,077	6,532	3,881	3,405	3,178	3,206
Total Common Equity	6,302	6,077	6,532	3,881	3,405	3,178	3,206
Common Stock	4,543	4,486	4,743	2,003	1,982	1,999	2,048
Retained Earnings	2,088	1,912	1,999	1,939	1,659	1,339	1,146
Accumulated Other Comprehensive Income / (Loss)	-329	-321	-210	-61	-235	-160	12
Noncontrolling Interest	13	9.97	12	10	13	7.99	11

This table presents STERIS's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022	6/30/2022
Total Assets	10,008	10,242	10,109	11,064	11,435	11,281	10,784	10,822	10,800	10,490	11,188
Total Current Assets	1,898	1,938	1,940	2,869	2,219	2,174	2,031	2,011	1,977	1,888	1,848
Cash & Equivalents	155	172	198	207	196	214	209	208	259	258	316
Accounts Receivable	915	923	893	1,008	964	940	888	865	823	780	764
Inventories, net	650	689	699	675	856	821	769	604	694	645	620
Prepaid Expenses	178	153	151	174	204	199	166	176	200	205	147
Other Current Nonoperating Assets	0.00	0.00	0.00	805	-	-	-	158	-	-	-
Plant, Property, & Equipment, net	1,922	1,930	1,834	1,765	1,844	1,744	1,726	1,633	1,671	1,572	1,573
Total Noncurrent Assets	6,189	6,375	6,334	6,429	7,372	7,363	7,027	7,178	7,152	7,029	7,767
Goodwill	4,044	4,151	4,057	4,071	4,112	4,040	3,887	3,879	3,853	3,705	4,321
Intangible Assets	1,923	2,004	2,049	2,119	2,987	3,058	2,865	2,077	3,031	3,077	3,193
Other Noncurrent Operating Assets	222	220	228	239	273	265	275	244	268	246	253
Total Liabilities & Shareholders' Equity	10,008	10,242	10,109	11,064	11,435	11,281	10,784	10,822	10,800	10,490	11,188
Total Liabilities	3,580	3,632	3,738	4,748	5,007	5,091	4,606	4,735	4,751	4,676	4,769
Total Current Liabilities	891	805	834	931	914	873	887	862	796	873	908
Short-Term Debt	125	80	80	86	78	71	63	60	60	151	151
Accounts Payable	238	235	232	252	277	294	261	264	242	233	229
Accrued Expenses	335	307	287	320	318	307	333	298	303	304	318
Current Deferred & Payable Income Tax Liabilities	0.00	5.85	57	14	25	32	64	40	25	17	38
Current Employee Benefit Liabilities	161	147	149	165	179	136	132	118	131	134	138
Other Current Liabilities	32	31	30	31	37	34	34	30	35	34	36
Other Current Nonoperating Liabilities	0.00	0.00	0.00	64	-	-	-	51	-	-	-
Total Noncurrent Liabilities	2,689	2,826	2,904	3,817	4,093	4,218	3,719	3,873	3,955	3,803	3,861
Long-Term Debt	2,039	2,156	2,236	3,120	3,231	3,366	2,860	3,019	3,002	2,874	2,846
Capital Lease Obligations	124	133	139	146	163	162	165	140	156	143	150
Noncurrent Deferred & Payable Income Tax Liabilities	453	463	456	480	621	613	618	618	725	710	791
Other Noncurrent Operating Liabilities	73	74	72	72	78	77	77	76	73	76	73
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	6,429	6,610	6,370	6,315	6,428	6,189	6,178	6,087	6,049	5,813	6,419
Total Preferred & Common Equity	6,416	6,593	6,355	6,302	6,415	6,178	6,168	6,077	6,038	5,802	6,408
Total Common Equity	6,416	6,593	6,355	6,302	6,415	6,178	6,168	6,077	6,038	5,802	6,408
Common Stock	4,405	4,491	4,500	4,543	4,534	4,519	4,498	4,486	4,632	4,705	4,739
Retained Earnings	2,386	2,268	2,178	2,088	2,134	2,046	1,981	1,912	1,771	1,695	2,057
Accumulated Other Comprehensive Income / (Loss)	-374	-166	-323	-329	-253	-387	-311	-321	-364	-598	-388
Noncontrolling Interest	12	17	16	13	13	11	10	9.97	10	11	12

This table displays calculated financial ratios and metrics derived from STERIS's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017
Period end date	3/31/2024	3/31/2023	3/31/2022	3/31/2021	3/31/2020	3/31/2019	3/31/2018	3/31/2017
Growth Metrics	-	-	-	-	-	-	-	-
Revenue Growth	13.28%	7.41%	35.91%	2.53%	8.94%	6.19%	0.28%	0.00%
EBITDA Growth	5.68%	24.63%	39.03%	5.12%	15.05%	9.59%	39.93%	0.00%
EBIT Growth	7.48%	72.74%	-17.74%	2.91%	30.19%	2.08%	76.99%	0.00%
NOPAT Growth	1.76%	74.56%	-11.88%	-4.25%	29.39%	3.32%	142.39%	0.00%
Net Income Growth	259.20%	-56.43%	-38.80%	-2.69%	33.84%	4.50%	163.60%	0.00%
EPS Growth	256.07%	-56.85%	-46.44%	-2.73%	34.08%	4.72%	164.84%	0.00%
Operating Cash Flow Growth	28.58%	10.53%	-0.70%	16.78%	9.46%	17.89%	7.91%	0.00%
Free Cash Flow Firm Growth	-101.33%	156.74%	-458.72%	-432.34%	-63.41%	113.30%	0.00%	0.00%
Invested Capital Growth	8.53%	-14.89%	73.17%	24.37%	5.90%	-4.46%	0.00%	0.00%
Revenue Q/Q Growth	-4.97%	-5.17%	-0.58%	1.65%	1.84%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	1.64%	72.53%	16.75%	-0.48%	1.99%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	3.14%	493.45%	-0.09%	-2.09%	2.61%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	-3.12%	656.23%	5.78%	-8.50%	3.97%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	-33.09%	463.64%	-12.50%	-8.43%	3.75%	0.00%	0.00%	0.00%
EPS Q/Q Growth	-33.28%	635.00%	-14.19%	-8.13%	3.70%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	4.18%	6.18%	-2.30%	-1.62%	3.56%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	-46.17%	239.73%	6.91%	-12.85%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	-10.15%	-10.80%	-2.96%	-0.72%	-1.66%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-
Gross Margin	43.17%	43.66%	44.59%	43.22%	43.55%	42.23%	41.71%	39.28%
EBITDA Margin	27.58%	29.56%	25.48%	24.91%	24.29%	23.00%	22.29%	15.97%
Operating Margin	16.27%	17.44%	11.31%	17.65%	17.72%	14.77%	15.26%	8.66%
EBIT Margin	16.49%	17.38%	10.80%	17.85%	17.78%	14.88%	15.48%	8.77%
Profit (Net Income) Margin	7.40%	2.33%	5.75%	12.77%	13.46%	10.95%	11.13%	4.23%
Tax Burden Percent	54.08%	15.55%	66.21%	76.69%	81.78%	82.58%	82.15%	59.92%
Interest Burden Percent	82.96%	86.30%	80.39%	93.30%	92.53%	89.13%	87.52%	80.57%
Effective Tax Rate	21.28%	18.24%	22.45%	23.32%	18.22%	17.42%	17.85%	40.08%
Return on Invested Capital (ROIC)	7.86%	7.40%	4.98%	8.55%	10.31%	8.01%	15.17%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-4.93%	-14.94%	-0.76%	6.68%	7.04%	4.66%	8.55%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-1.73%	-5.73%	-0.32%	2.31%	2.04%	1.50%	2.96%	0.00%
Return on Equity (ROE)	6.13%	1.68%	4.65%	10.86%	12.35%	9.52%	18.13%	0.00%
Cash Return on Invested Capital (CROIC)	-0.33%	23.50%	-48.59%	-13.17%	4.57%	12.57%	-184.83%	0.00%
Operating Return on Assets (OROA)	7.74%	7.09%	5.07%	9.23%	10.25%	8.06%	7.80%	0.00%
Return on Assets (ROA)	3.47%	0.95%	2.70%	6.61%	7.76%	5.93%	5.61%	0.00%
Return on Common Equity (ROCE)	6.12%	1.67%	4.64%	10.82%	12.31%	9.49%	18.06%	0.00%
Return on Equity Simple (ROE_SIMPLE)	6.03%	1.74%	3.72%	10.23%	11.98%	9.59%	9.10%	0.00%
Net Operating Profit after Tax (NOPAT)	658	647	371	421	439	339	329	136
NOPAT Margin	12.81%	14.26%	8.77%	13.53%	14.49%	12.20%	12.54%	5.19%
Net Nonoperating Expense Percent (NNEP)	12.79%	22.35%	5.73%	1.87%	3.27%	3.35%	6.62%	0.00%
Cost of Revenue to Revenue	56.83%	56.34%	55.41%	56.78%	56.45%	57.77%	58.29%	60.72%
SG&A Expenses to Revenue	24.37%	24.04%	31.22%	23.53%	23.65%	24.08%	24.12%	26.10%
R&D to Revenue	2.02%	2.17%	2.05%	2.13%	2.16%	2.27%	2.32%	2.27%
Operating Expenses to Revenue	26.89%	26.22%	33.27%	25.57%	25.83%	27.46%	26.45%	30.62%
Earnings before Interest and Taxes (EBIT)	847	788	456	555	539	414	406	229
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,417	1,341	1,076	774	736	640	584	417
Valuation Ratios	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.53	3.10	3.64	4.09	3.37	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	198.05	155.13	0.00	0.00	23.72	0.00	0.00	0.00
Price to Revenue (P/Rev)	4.32	4.15	5.62	5.10	3.79	0.00	0.00	0.00
Price to Earnings (P/E)	58.73	175.79	97.39	39.92	28.15	0.00	0.00	0.00
Dividend Yield	0.90%	0.97%	0.71%	0.84%	1.07%	1.08%	1.38%	1.68%
Earnings Yield	1.70%	0.57%	1.03%	2.51%	3.55%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.91	2.72	2.82	3.20	2.84	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	4.94	4.81	6.31	5.61	4.11	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	17.90	16.28	24.77	22.52	16.92	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	29.95	27.70	58.42	31.43	23.10	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	38.55	33.76	71.94	41.46	28.36	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	26.07	28.85	38.93	25.28	21.09	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	10.64	0.00	0.00	63.92	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-
Debt to Equity	0.53	0.53	0.50	0.46	0.38	0.37	0.41	0.00
Long-Term Debt to Equity	0.52	0.52	0.47	0.46	0.37	0.37	0.41	0.00
Financial Leverage	0.35	0.38	0.43	0.35	0.29	0.32	0.35	0.00
Leverage Ratio	1.76	1.76	1.72	1.64	1.59	1.60	1.62	0.00
Compound Leverage Factor	1.46	1.52	1.39	1.53	1.47	1.43	1.41	0.00
Debt to Total Capital	34.67%	34.58%	33.14%	31.39%	27.31%	27.08%	29.03%	0.00%
Short-Term Debt to Total Capital	0.89%	0.64%	1.46%	0.00%	0.42%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	33.78%	33.94%	31.68%	31.39%	26.89%	27.08%	29.03%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.14%	0.11%	0.13%	0.18%	0.27%	0.18%	0.25%	0.00%
Common Equity to Total Capital	65.19%	65.31%	66.74%	68.43%	72.41%	72.74%	70.72%	0.00%
Debt to EBITDA	2.37	2.40	3.01	2.30	1.74	1.85	2.25	0.00
Net Debt to EBITDA	2.22	2.24	2.69	2.02	1.31	1.50	1.91	0.00
Long-Term Debt to EBITDA	2.30	2.35	2.88	2.30	1.72	1.85	2.25	0.00
Debt to NOPAT	5.09	4.98	8.75	4.23	2.92	3.49	4.01	0.00
Net Debt to NOPAT	4.78	4.65	7.81	3.71	2.20	2.84	3.39	0.00
Long-Term Debt to NOPAT	4.96	4.88	8.37	4.23	2.88	3.49	4.01	0.00
Altman Z-Score	4.00	3.42	3.77	4.83	4.87	0.00	0.00	0.00
Noncontrolling Interest Sharing Ratio	0.19%	0.18%	0.22%	0.32%	0.32%	0.30%	0.35%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-
Current Ratio	3.08	2.33	2.04	2.10	2.43	2.27	2.48	0.00
Quick Ratio	1.31	1.25	1.24	1.44	1.80	1.67	1.83	0.00
Cash Flow Metrics	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-27	2,053	-3,618	-648	195	532	-4,003	0.00
Operating Cash Flow to CapEx	275.76%	217.90%	239.59%	288.92%	280.74%	292.97%	280.13%	252.35%
Free Cash Flow to Firm to Interest Expense	-0.19	19.02	-40.43	-17.42	4.84	11.83	-79.07	0.00
Operating Cash Flow to Interest Expense	6.74	7.01	7.65	18.55	14.66	11.99	9.04	9.53
Operating Cash Flow Less CapEx to Interest Expense	4.30	3.79	4.46	12.13	9.44	7.89	5.81	5.75
Efficiency Ratios	-	-	-	-	-	-	-	-
Asset Turnover	0.47	0.41	0.47	0.52	0.58	0.54	0.50	0.00
Accounts Receivable Turnover	5.49	5.45	6.00	5.20	5.31	5.14	4.96	0.00
Inventory Turnover	4.57	4.33	5.26	6.10	7.25	7.76	7.42	0.00
Fixed Asset Turnover	3.02	2.85	3.03	2.65	2.83	2.72	2.59	0.00
Accounts Payable Turnover	11.32	10.43	12.23	11.52	11.32	11.13	11.24	0.00
Days Sales Outstanding (DSO)	66.53	66.95	60.86	70.23	68.74	71.06	73.57	0.00
Days Inventory Outstanding (DIO)	79.92	84.23	69.41	59.85	50.33	47.01	49.17	0.00
Days Payable Outstanding (DPO)	32.24	34.99	29.84	31.68	32.24	32.79	32.47	0.00
Cash Conversion Cycle (CCC)	114.21	116.19	100.43	98.40	86.83	85.27	90.26	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-
Invested Capital	8,719	8,034	9,440	5,451	4,383	4,139	4,332	0.00
Invested Capital Turnover	0.61	0.52	0.57	0.63	0.71	0.66	1.21	0.00
Increase / (Decrease) in Invested Capital	686	-1,406	3,989	1,068	244	-193	4,332	0.00
Enterprise Value (EV)	25,373	21,834	26,659	17,433	12,454	0.00	0.00	0.00
Market Capitalization	22,215	18,814	23,751	15,863	11,476	0.00	0.00	0.00
Book Value per Share	$63.78	$61.21	$65.24	$45.47	$40.15	$37.59	$0.00	$0.00
Tangible Book Value per Share	$1.14	$1.22	($11.99)	($0.51)	$5.70	$2.96	$0.00	$0.00
Total Capital	9,667	9,305	9,788	5,672	4,703	4,369	4,533	0.00
Total Debt	3,352	3,218	3,243	1,780	1,284	1,183	1,316	0.00
Total Long-Term Debt	3,266	3,158	3,101	1,780	1,265	1,183	1,316	0.00
Net Debt	3,145	3,010	2,895	1,560	965	963	1,114	0.00
Capital Expenditures (CapEx)	353	347	286	239	210	184	163	168
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,817	1,001	751	413	421	368	390	0.00
Debt-free Net Working Capital (DFNWC)	2,024	1,210	1,100	634	740	589	591	0.00
Net Working Capital (NWC)	1,938	1,150	957	634	720	589	591	0.00
Net Nonoperating Expense (NNE)	278	541	128	24	31	35	37	25
Net Nonoperating Obligations (NNO)	2,404	1,947	2,895	1,560	965	953	1,114	0.00
Total Depreciation and Amortization (D&A)	570	553	620	219	197	226	178	188
Debt-free, Cash-free Net Working Capital to Revenue	35.36%	22.07%	17.79%	13.30%	13.88%	13.22%	14.87%	0.00%
Debt-free Net Working Capital to Revenue	39.39%	26.67%	26.04%	20.40%	24.42%	21.15%	22.56%	0.00%
Net Working Capital to Revenue	37.71%	25.34%	22.65%	20.40%	23.77%	21.15%	22.56%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.83	$1.07	$2.50	$4.66	$4.81	$3.59	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	197.80M	197.30M	200.16M	170.74M	84.92M	84.54M	0.00	0.00
Adjusted Diluted Earnings per Share	$3.81	$1.07	$2.48	$4.63	$4.76	$3.56	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	197.80M	197.30M	200.16M	170.74M	84.92M	84.54M	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	197.80M	197.30M	200.16M	170.74M	84.92M	84.54M	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	679	647	371	418	440	365	329	171
Normalized NOPAT Margin	13.21%	14.27%	8.77%	13.46%	14.51%	13.12%	12.54%	6.53%
Pre Tax Income Margin	13.68%	15.00%	8.69%	16.65%	16.46%	13.26%	13.55%	7.07%
Debt Service Ratios	-	-	-	-	-	-	-	-
EBIT to Interest Expense	5.87	7.30	5.10	14.92	13.38	9.20	8.01	5.15
NOPAT to Interest Expense	4.56	5.99	4.14	11.31	10.90	7.54	6.49	3.04
EBIT Less CapEx to Interest Expense	3.42	4.08	1.90	8.50	8.16	5.11	4.78	1.37
NOPAT Less CapEx to Interest Expense	2.11	2.77	0.95	4.89	5.68	3.45	3.26	-0.73
Payout Ratios	-	-	-	-	-	-	-	-
Dividend Payout Ratio	54.82%	175.56%	81.05%	35.38%	30.62%	37.44%	36.48%	93.20%
Augmented Payout Ratio	57.92%	467.17%	104.02%	39.07%	43.19%	64.18%	58.94%	181.34%

This table displays calculated financial ratios and metrics derived from STERIS's official financial filings.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022	6/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	5.61%	7.33%	8.12%	15.87%	6.72%	3.14%	2.33%	13.46%	0.58%	0.30%	19.42%
EBITDA Growth	1.24%	-4.41%	-5.55%	-56.66%	12.95%	302.27%	13.69%	147.96%	0.72%	-173.95%	287.79%
EBIT Growth	8.44%	11.29%	3.27%	-66.40%	20.99%	162.81%	26.34%	414.76%	-8.03%	-372.49%	2,299.93%
NOPAT Growth	4.73%	14.93%	-4.32%	-70.49%	20.95%	169.22%	19.11%	509.41%	-7.81%	-336.95%	1,196.48%
Net Income Growth	22.95%	29.93%	17.57%	-100.54%	14.29%	136.91%	11.77%	259.18%	-13.82%	-552.76%	605.68%
EPS Growth	23.24%	30.17%	16.80%	-101.06%	14.52%	136.83%	13.64%	208.20%	-12.68%	-556.52%	558.33%
Operating Cash Flow Growth	14.28%	71.62%	8.04%	18.08%	41.67%	40.71%	21.31%	25.66%	-15.86%	-39.40%	137.87%
Free Cash Flow Firm Growth	355.44%	233.46%	66.78%	-123.65%	-160.03%	-184.60%	-34.81%	153.36%	121.27%	116.62%	110.23%
Invested Capital Growth	-11.79%	-8.01%	-4.76%	8.53%	7.75%	9.76%	-2.08%	-14.89%	-7.41%	-10.70%	-4.17%
Revenue Q/Q Growth	3.13%	3.86%	14.63%	-20.03%	4.81%	4.63%	22.85%	-20.78%	1.29%	3.81%	-4.48%
EBITDA Q/Q Growth	13.32%	3.60%	-17.55%	6.19%	7.00%	2.37%	-62.16%	172.56%	291.61%	-157.53%	-3.45%
EBIT Q/Q Growth	15.51%	4.34%	-18.25%	15.27%	18.55%	-3.19%	-73.40%	296.32%	161.54%	-294.73%	69.06%
NOPAT Q/Q Growth	8.95%	15.17%	-24.41%	15.34%	19.55%	-4.11%	-76.69%	352.60%	168.42%	-265.00%	94.29%
Net Income Q/Q Growth	14.63%	3.87%	14,625.05%	-100.71%	21.14%	-6.01%	-33.79%	51.60%	139.12%	-384.62%	112.77%
EPS Q/Q Growth	15.89%	3.42%	7,400.00%	-101.41%	22.41%	-7.20%	-33.51%	51.61%	139.37%	-386.36%	80.33%
Operating Cash Flow Q/Q Growth	32.75%	-17.45%	19.21%	-12.51%	99.35%	-48.03%	30.27%	4.97%	98.01%	-55.20%	34.95%
Free Cash Flow Firm Q/Q Growth	41.82%	61.93%	218.29%	7.31%	25.90%	-302.36%	-83.23%	138.70%	4.42%	55.93%	113.58%
Invested Capital Q/Q Growth	-2.80%	2.09%	-1.06%	-10.15%	1.36%	5.70%	12.75%	-10.80%	3.25%	-5.70%	-2.01%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	44.53%	43.55%	44.74%	40.19%	43.15%	44.11%	44.70%	42.47%	42.89%	44.34%	44.77%
EBITDA Margin	27.27%	24.82%	24.88%	34.59%	28.45%	27.87%	28.48%	92.48%	26.88%	-14.21%	25.64%
Operating Margin	17.90%	16.53%	14.50%	21.97%	17.45%	15.47%	16.71%	77.69%	15.69%	-25.52%	13.70%
EBIT Margin	18.08%	16.15%	16.07%	22.54%	17.61%	15.57%	16.83%	77.72%	15.53%	-25.57%	13.63%
Profit (Net Income) Margin	12.64%	11.38%	11.37%	-0.09%	10.86%	9.40%	10.46%	19.41%	10.14%	-26.26%	9.58%
Tax Burden Percent	75.75%	77.57%	83.04%	-0.47%	74.34%	74.65%	74.22%	26.04%	76.92%	94.65%	82.07%
Interest Burden Percent	92.30%	90.83%	85.22%	85.65%	82.96%	80.84%	83.75%	95.91%	84.88%	108.51%	85.62%
Effective Tax Rate	24.21%	22.32%	20.15%	20.08%	21.62%	22.49%	21.71%	11.24%	23.08%	0.00%	17.93%
Return on Invested Capital (ROIC)	8.02%	7.44%	6.85%	10.77%	6.85%	6.03%	6.52%	35.80%	6.16%	-9.23%	5.68%
ROIC Less NNEP Spread (ROIC-NNEP)	7.55%	6.74%	6.75%	1.72%	5.67%	5.01%	5.43%	16.09%	5.39%	-12.51%	5.02%
Return on Net Nonoperating Assets (RNNOA)	3.18%	2.94%	2.76%	0.60%	2.84%	2.63%	2.46%	6.17%	2.58%	-6.21%	2.28%
Return on Equity (ROE)	11.19%	10.38%	9.62%	11.37%	9.68%	8.66%	8.99%	41.97%	8.74%	-15.44%	7.96%
Cash Return on Invested Capital (CROIC)	19.99%	15.68%	12.24%	-0.33%	4.83%	2.93%	9.44%	23.50%	6.45%	11.04%	8.99%
Operating Return on Assets (OROA)	9.10%	7.99%	8.05%	10.58%	7.42%	6.58%	6.99%	31.70%	6.61%	-10.98%	5.59%
Return on Assets (ROA)	6.37%	5.63%	5.70%	-0.04%	4.57%	3.97%	4.34%	7.92%	4.31%	-11.28%	3.93%
Return on Common Equity (ROCE)	11.17%	10.36%	9.60%	11.35%	9.66%	8.64%	8.97%	41.90%	8.73%	-15.42%	7.94%
Return on Equity Simple (ROE_SIMPLE)	7.31%	6.62%	6.32%	0.00%	8.85%	8.91%	1.93%	0.00%	-0.48%	-0.16%	5.86%
Net Operating Profit after Tax (NOPAT)	186	171	148	196	177	148	155	664	147	-214	130
NOPAT Margin	13.56%	12.84%	11.58%	17.56%	13.68%	11.99%	13.08%	68.96%	12.07%	-17.87%	11.24%
Net Nonoperating Expense Percent (NNEP)	0.47%	0.70%	0.10%	9.06%	1.17%	1.02%	1.09%	19.71%	0.77%	3.28%	0.65%
Return On Investment Capital (ROIC_SIMPLE)	2.13%	-	-	-	1.79%	-	-	-	-	-	-
Cost of Revenue to Revenue	55.47%	56.45%	55.26%	59.81%	56.85%	55.89%	55.30%	57.53%	57.11%	55.66%	55.23%
SG&A Expenses to Revenue	24.48%	24.78%	26.23%	13.63%	23.76%	26.52%	25.90%	13.26%	25.09%	26.92%	28.93%
R&D to Revenue	2.00%	2.03%	2.00%	2.26%	1.95%	2.12%	2.09%	2.42%	2.10%	2.08%	2.14%
Operating Expenses to Revenue	26.63%	27.02%	30.24%	18.22%	25.70%	28.64%	27.99%	-35.22%	27.20%	69.87%	31.08%
Earnings before Interest and Taxes (EBIT)	248	215	206	252	229	193	199	749	189	-307	158
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	374	330	318	386	369	345	337	891	327	-171	296
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.16	3.63	3.42	3.53	3.35	3.48	3.56	3.10	3.02	2.83	3.17
Price to Tangible Book Value (P/TBV)	45.20	54.56	87.25	198.05	0.00	0.00	0.00	155.13	0.00	0.00	0.00
Price to Revenue (P/Rev)	3.76	4.49	4.15	4.32	4.59	4.67	4.82	4.15	3.82	3.44	4.26
Price to Earnings (P/E)	43.39	55.01	54.27	58.73	37.96	39.04	184.26	175.79	0.00	0.00	53.92
Dividend Yield	1.06%	0.88%	0.95%	0.90%	0.91%	0.89%	0.84%	0.97%	0.98%	1.07%	0.85%
Earnings Yield	2.30%	1.82%	1.84%	1.70%	2.63%	2.56%	0.54%	0.57%	0.00%	0.00%	1.85%
Enterprise Value to Invested Capital (EV/IC)	2.62	2.97	2.78	2.91	2.56	2.60	2.75	2.72	2.36	2.22	2.50
Enterprise Value to Revenue (EV/Rev)	4.16	4.91	4.58	4.94	5.30	5.40	5.45	4.81	4.44	4.05	4.85
Enterprise Value to EBITDA (EV/EBITDA)	16.22	18.96	17.21	17.90	12.77	13.09	18.00	16.28	27.31	25.54	19.68
Enterprise Value to EBIT (EV/EBIT)	25.07	29.85	28.10	29.95	18.12	18.70	29.98	27.70	159.82	129.57	40.73
Enterprise Value to NOPAT (EV/NOPAT)	32.91	38.79	36.80	38.55	21.57	22.21	37.03	33.76	0.00	0.00	51.82
Enterprise Value to Operating Cash Flow (EV/OCF)	19.64	23.75	24.08	26.07	26.55	29.30	30.85	28.85	29.78	25.74	28.29
Enterprise Value to Free Cash Flow (EV/FCFF)	12.29	18.14	22.15	0.00	54.87	92.68	28.79	10.64	35.13	18.96	27.26
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.36	0.36	0.39	0.53	0.54	0.58	0.50	0.53	0.53	0.55	0.49
Long-Term Debt to Equity	0.34	0.35	0.37	0.52	0.53	0.57	0.49	0.52	0.52	0.52	0.47
Financial Leverage	0.42	0.44	0.41	0.35	0.50	0.52	0.45	0.38	0.48	0.50	0.45
Leverage Ratio	1.67	1.68	1.66	1.76	1.78	1.81	1.74	1.76	1.77	1.80	1.79
Compound Leverage Factor	1.54	1.53	1.42	1.51	1.48	1.47	1.46	1.69	1.51	1.95	1.53
Debt to Total Capital	26.24%	26.38%	27.82%	34.67%	35.07%	36.77%	33.33%	34.58%	34.72%	35.28%	32.90%
Short-Term Debt to Total Capital	1.43%	0.89%	0.91%	0.89%	0.79%	0.72%	0.68%	0.64%	0.65%	1.68%	1.58%
Long-Term Debt to Total Capital	24.81%	25.49%	26.91%	33.78%	34.28%	36.05%	32.64%	33.94%	34.08%	33.59%	31.32%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.14%	0.19%	0.18%	0.14%	0.13%	0.11%	0.11%	0.11%	0.11%	0.13%	0.12%
Common Equity to Total Capital	73.61%	73.43%	72.00%	65.19%	64.80%	63.12%	66.56%	65.31%	65.17%	64.60%	66.98%
Debt to EBITDA	1.65	1.72	1.76	2.37	1.79	1.89	2.24	2.40	4.14	4.18	2.67
Net Debt to EBITDA	1.54	1.59	1.62	2.22	1.69	1.78	2.08	2.24	3.81	3.84	2.41
Long-Term Debt to EBITDA	1.56	1.66	1.70	2.30	1.75	1.86	2.19	2.35	4.06	3.98	2.55
Debt to NOPAT	3.36	3.52	3.77	5.09	3.02	3.22	4.60	4.98	-27.67	-129.03	7.04
Net Debt to NOPAT	3.13	3.26	3.46	4.78	2.85	3.02	4.29	4.65	-25.44	-118.52	6.33
Long-Term Debt to NOPAT	3.17	3.40	3.64	4.96	2.95	3.15	4.50	4.88	-27.15	-122.88	6.70
Altman Z-Score	4.48	4.98	4.50	3.82	3.45	3.39	3.73	3.41	3.17	2.81	3.39
Noncontrolling Interest Sharing Ratio	0.20%	0.22%	0.21%	0.19%	0.18%	0.19%	0.17%	0.18%	0.18%	0.17%	0.17%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.13	2.41	2.33	3.08	2.43	2.49	2.29	2.33	2.48	2.16	2.03
Quick Ratio	1.20	1.36	1.31	1.31	1.27	1.32	1.24	1.25	1.36	1.19	1.19
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	1,330	938	579	-490	-521	-703	347	2,070	867	831	533
Operating Cash Flow to CapEx	373.02%	246.07%	281.03%	278.51%	244.90%	192.39%	422.14%	312.63%	253.87%	125.49%	202.14%
Free Cash Flow to Firm to Interest Expense	69.65	47.68	19.06	-13.56	-13.37	-19.02	10.73	67.65	30.37	31.80	23.49
Operating Cash Flow to Interest Expense	17.43	12.75	10.00	7.06	7.48	3.96	8.69	7.05	7.20	3.97	10.22
Operating Cash Flow Less CapEx to Interest Expense	12.76	7.57	6.44	4.52	4.42	1.90	6.63	4.80	4.36	0.81	5.16
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.50	0.49	0.50	0.47	0.42	0.42	0.42	0.41	0.43	0.43	0.41
Accounts Receivable Turnover	5.75	5.72	5.88	5.49	5.24	5.35	5.53	5.45	6.07	6.19	6.33
Inventory Turnover	4.06	4.01	4.05	4.57	3.40	3.54	3.70	4.33	4.10	4.33	4.39
Fixed Asset Turnover	2.87	2.90	2.94	3.02	2.66	2.77	2.77	2.85	3.00	3.10	3.11
Accounts Payable Turnover	11.86	11.47	12.08	11.32	10.16	9.85	10.50	10.43	11.74	11.56	11.56
Days Sales Outstanding (DSO)	63.53	63.87	62.07	66.53	69.64	68.24	66.05	66.95	60.08	58.92	57.63
Days Inventory Outstanding (DIO)	89.95	90.91	90.07	79.92	107.22	103.10	98.61	84.23	89.09	84.35	83.09
Days Payable Outstanding (DPO)	30.78	31.83	30.22	32.24	35.92	37.06	34.76	34.99	31.08	31.56	31.58
Cash Conversion Cycle (CCC)	122.70	122.95	121.92	114.21	140.94	134.29	129.90	116.19	118.09	111.71	109.14
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	8,561	8,808	8,627	8,719	9,705	9,575	9,058	8,034	9,007	8,724	9,250
Invested Capital Turnover	0.59	0.58	0.59	0.61	0.50	0.50	0.50	0.52	0.51	0.52	0.51
Increase / (Decrease) in Invested Capital	-1,144	-767	-431	686	698	851	-192	-1,406	-721	-1,045	-403
Enterprise Value (EV)	22,435	26,133	23,985	25,373	24,804	24,866	24,876	21,834	21,227	19,345	23,170
Market Capitalization	20,290	23,919	21,713	22,215	21,515	21,469	21,987	18,814	18,259	16,424	20,327
Book Value per Share	$65.00	$66.86	$64.25	$63.78	$64.93	$62.54	$62.53	$61.21	$60.49	$58.01	$64.02
Tangible Book Value per Share	$4.55	$4.45	$2.52	$1.14	($6.92)	($9.31)	($5.91)	$1.22	($8.48)	($9.80)	($11.06)
Total Capital	8,716	8,980	8,825	9,667	9,900	9,788	9,267	9,305	9,266	8,982	9,567
Total Debt	2,287	2,369	2,455	3,352	3,472	3,599	3,088	3,218	3,218	3,168	3,148
Total Long-Term Debt	2,162	2,289	2,375	3,266	3,394	3,528	3,025	3,158	3,158	3,017	2,997
Net Debt	2,132	2,197	2,257	3,145	3,277	3,386	2,880	3,010	2,958	2,910	2,831
Capital Expenditures (CapEx)	89	102	108	91	119	76	67	69	81	83	115
Debt-free, Cash-free Net Working Capital (DFCFNWC)	977	1,040	988	1,817	1,188	1,158	999	1,001	981	908	774
Debt-free Net Working Capital (DFNWC)	1,132	1,212	1,186	2,024	1,384	1,372	1,208	1,210	1,240	1,166	1,091
Net Working Capital (NWC)	1,007	1,132	1,106	1,938	1,305	1,301	1,144	1,150	1,180	1,015	940
Net Nonoperating Expense (NNE)	13	19	2.61	197	37	32	31	477	23	101	19
Net Nonoperating Obligations (NNO)	2,132	2,197	2,257	2,404	3,277	3,386	2,880	1,947	2,958	2,910	2,831
Total Depreciation and Amortization (D&A)	126	115	113	135	141	152	138	142	138	136	139
Debt-free, Cash-free Net Working Capital to Revenue	18.09%	19.53%	18.87%	35.36%	25.37%	25.17%	21.90%	22.07%	20.50%	19.01%	16.22%
Debt-free Net Working Capital to Revenue	20.96%	22.77%	22.66%	39.39%	29.55%	29.82%	26.47%	26.67%	25.93%	24.42%	22.85%
Net Working Capital to Revenue	18.65%	21.26%	21.13%	37.71%	27.87%	28.27%	25.08%	25.34%	24.67%	21.26%	19.69%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.76	$1.52	$1.47	($0.01)	$1.42	$1.17	$1.25	$1.87	$1.24	($3.15)	$1.11
Adjusted Weighted Average Basic Shares Outstanding	98.25M	98.71M	197.23M	197.80M	197.63M	197.60M	197.56M	197.30M	198.57M	199.65M	200.03M
Adjusted Diluted Earnings per Share	$1.75	$1.51	$1.46	($0.02)	$1.42	$1.16	$1.25	$1.88	$1.24	($3.15)	$1.10
Adjusted Weighted Average Diluted Shares Outstanding	98.25M	98.71M	197.23M	197.80M	197.63M	197.60M	197.56M	197.30M	198.57M	199.65M	200.03M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	98.25M	98.71M	197.23M	197.80M	197.63M	197.60M	197.56M	197.30M	198.57M	199.65M	200.03M
Normalized Net Operating Profit after Tax (NOPAT)	188	173	169	217	178	148	155	665	147	129	130
Normalized NOPAT Margin	13.69%	13.00%	13.18%	19.42%	13.68%	11.99%	13.09%	68.99%	12.07%	10.74%	11.24%
Pre Tax Income Margin	16.69%	14.67%	13.70%	19.30%	14.61%	12.59%	14.09%	74.54%	13.19%	-27.74%	11.67%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	12.98	10.91	6.77	6.97	5.87	5.22	6.15	24.47	6.61	-11.75	6.95
NOPAT to Interest Expense	9.74	8.68	4.88	5.43	4.56	4.02	4.79	21.71	5.14	-8.21	5.73
EBIT Less CapEx to Interest Expense	8.31	5.73	3.21	4.43	2.81	3.16	4.10	22.21	3.78	-14.92	1.90
NOPAT Less CapEx to Interest Expense	5.06	3.49	1.32	2.89	1.50	1.96	2.73	19.45	2.30	-11.38	0.68
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	46.31%	49.98%	53.10%	54.82%	36.03%	35.17%	159.18%	175.56%	-622.55%	-1,968.20%	48.10%
Augmented Payout Ratio	91.38%	75.90%	69.84%	57.92%	65.26%	80.20%	405.39%	467.17%	-1,248.37%	-3,050.28%	66.69%

Frequently Asked Questions About STERIS's Financials

When does STERIS's financial year end?

According to the most recent income statement we have on file, STERIS's fiscal year ends in March. Their fiscal year 2024 ended on March 31, 2024.

How has STERIS's net income changed over the last 7 years?

STERIS's net income appears to be on an upward trend, with a most recent value of $380.08 million in 2024, rising from $110.63 million in 2017. The previous period was $105.81 million in 2023. Find out what analysts predict for STERIS in the coming months.

What is STERIS's operating income?

STERIS's total operating income in 2024 was $836.12 million, based on the following breakdown:

Total Gross Profit: $2.22 billion
Total Operating Expenses: $1.38 billion

How has STERIS revenue changed over the last 7 years?

Over the last 7 years, STERIS's total revenue changed from $2.61 billion in 2017 to $5.14 billion in 2024, a change of 96.7%.

How much debt does STERIS have?

STERIS's total liabilities were at $4.75 billion at the end of 2024, a 0.3% increase from 2023, and a 139.4% increase since 2018.

How much cash does STERIS have?

In the past 6 years, STERIS's cash and equivalents has ranged from $201.53 million in 2018 to $348.32 million in 2022, and is currently $207.02 million as of their latest financial filing in 2024.

How has STERIS's book value per share changed over the last 7 years?

Over the last 7 years, STERIS's book value per share changed from 0.00 in 2017 to 63.78 in 2024, a change of 6,377.8%.

Related Companies

This page (NYSE:STE) was last updated on 5/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

STERIS (STE) Financials

Frequently Asked Questions About STERIS's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

STERIS (STE) Financials

Annual Income Statements for STERIS

Quarterly Income Statements for STERIS

Annual Cash Flow Statements for STERIS

Quarterly Cash Flow Statements for STERIS

Annual Balance Sheets for STERIS

Quarterly Balance Sheets for STERIS

Annual Metrics And Ratios for STERIS

Quarterly Metrics And Ratios for STERIS

Frequently Asked Questions About STERIS's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools